Black Lamp Laboratory: AI ushering in a new era of intelligent experiments

With the rapid development of artificial intelligence technology, the wave of AI empowering various industries is surging. In this technological revolution, the Black Lab has emerged. This 24/7 unmanned fully automated laboratory, leading the way in the fields of medical testing and drug development, has gradually expanded to more diverse scenarios, greatly improving accuracy and efficiency, while reducing costs and driving industry acceleration and leapfrog upgrades. In the field of AI pharmaceuticals, the leading company Yingxi Intelligent released the "world's first AI-assisted decision-making automated laboratory" in November 2024. In March of this year, the "fully automatic unmanned Black Lab" jointly created by the Institute of Brain Science and Brain-Like Intelligence of CloudMinds officially made its debut. AI pharmaceutical company Jingtai Technology has used the powerful computing predictive capability of the Black Lab to help Pfizer predict the crystal structure of the new oral medication for COVID-19, reducing the time to market for the drug by 6 months, with sales reaching $18.9 billion in 2022. Regarding the background and original intention of the construction of the Black Lab, Lin Siyuan, the director of the GLI Business Center of CloudMinds, said that the laboratory product was internally called "Zhi Hui Experiment Laboratory", aiming to achieve intelligent empowerment and a universal future. Life science research is transitioning from single point experiments to large-scale queue studies, such as projects involving millions of genomes and brain science plans, traditional laboratories are facing problems such as throughput bottlenecks and fluctuations in testing accuracy. The emergence of the Black Lab provides new ideas and solutions to address these issues.